AI-driven Lead Discovery
- Computer based de novo drug design background
- The AIDD Module in ADMET Predictor®
- Using chemically intelligent SMIRKS transformations to generate molecules
- Synthetic feasibility assessment
- Incorporating pharmacokinetic and ADMET liability predictions
- Penalizing out of scope predictions
- Using capping values when objective function value is “good enough”
- Using external programs to compute objective functions
- Selecting Pareto optimal compounds
- AIDD module demonstration
By Michael S. Lawless, David Miller, and Marvin Waldman
Presented at ACS Spring 2022, March 20-24 In person & Virtual, San Diego, Ca